Fate Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fate Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $109k | 111k | 0.98 |
| 2022-12-31 | $3.8M | 381k | 10.09 |
| 2022-09-30 | $6.7M | 300k | 22.41 |
| 2022-06-30 | $1.3M | 54k | 24.77 |
| 2022-03-31 | $297k | 7.7k | 38.75 |
| 2021-06-30 | $6.2M | 71k | 86.79 |
| 2021-03-31 | $5.3M | 64k | 82.45 |
| 2020-12-31 | $3.0M | 33k | 90.92 |
| 2020-09-30 | $288k | 7.2k | 39.98 |
| 2017-12-31 | $177k | 29k | 6.12 |
| 2017-09-30 | $257k | 65k | 3.95 |
| 2017-06-30 | $206k | 64k | 3.24 |
| 2017-03-31 | $188k | 41k | 4.55 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management